Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Beovu (Brolucizumab) is an eye injection used to treat neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME). It works by inhibiting vascular endothelial growth factor (VEGF), a protein that promotes abnormal blood vessel formation in the eye. Beovu helps to manage the growth of these vessels, aiming to preserve vision in patients with AMD or DME. Beovu is administered as an injection into the eye by healthcare professionals.
Fact Table | |
Formula | C1428H2280N404O442S10 |
License | US FDA, EMA |
Bioavailability | N/A (Intravitreal) |
Legal status | Prescription only (Rx) |
Chemical Name | Brolucizumab-dbll |
Elimination half-life | ~4.4 days (ocular) |
Dosage (Strength) | 6 mg/0.05 mL solution (Intravitreal injection) |
Pregnancy | Consult a doctor (Category C) |
Brands | Beovu |
Protein binding | High (to VEGF-A) |
PubChem CID | 126313196 |
MedlinePlus | a620043 |
ChEBI | CHEBI:177749 |
ATC code | S01LA06 |
DrugBank | DB14761 |
KEGG | D11250 |
Routes of administration | Intravitreal injection |
Beovu is injected directly into the eye by a healthcare professional trained in administering intravitreal injections. The typical starting dose is 6 mg (0.05 mL of a 120 mg/mL solution). Patients typically receive this dose once every month for the first three doses for AMD or once every six weeks for the first five doses for DME. Afterward, the dosing frequency may change to once every eight to twelve weeks as directed by a physician. It's important for patients to follow their doctor's specific instructions about follow-up appointments and treatment schedules.
Brolucizumab-dbll is the active ingredient in Beovu.
Avoid taking or using this medication if any of the following apply:
In treating eye conditions, Beovu commonly causes blurred vision, cataracts (cloudy areas in the eye lens), eye bleeding, floaters (tiny spots in your vision), eye pain, increased eye pressure, and eye redness or irritation. Patients might also experience eye dryness, increased tearing, sensations of something in the eye, and vision changes.
More severe issues with Beovu include serious allergic reactions, infections inside the eye, retina detachment (the back layer of the eye pulling away), blood vessel blockages in the retina, and significantly increased eye pressure. Patients should promptly report any sudden vision changes, intense eye pain, or major discomfort to their healthcare provider. Regular eye check-ups are important for those on Beovu treatment.